NASDAQ$NUTX

Nutex Health Inc · Q3 2013 earnings

Q3 2013 earnings ·

Headline financials

Total Revenue

$755K

No prior period
Capital Expenditures

-$6.45K

No prior period
Free Cash Flow

-$152K

No prior period
Net Income

-$158K

No prior period
Operating Income

-$158K

No prior period
Gross Profit

$263K

No prior period

Revenue & EPS history

Nutex Health Inc · Revenue · Quarterly

$755K

Q3 2013

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports

Historical avg

+1.9%

Avg return

Earnings day

+17.2%

Avg return

5 days after

+21.1%

Avg return

30 days after

62%

8 / 13 earnings

Positive

+22.4%

Q1 2022

Best reaction

-14.3%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.4%+8.0%+14.4%
Q4 2025-14.3%-14.1%-4.2%
Q3 2025+0.0%+32.9%+64.1%
Q1 2025+1.0%+40.2%+0.2%
Q3 2024+6.3%+38.2%+39.3%
Q2 2024+0.9%+62.7%+173.1%
Q1 2024+6.2%+14.8%+0.7%
Q3 2023+0.0%-6.0%-22.8%
Q2 2023+3.6%+0.9%-20.1%
Q1 2023+8.9%+10.3%-17.8%
Q3 2022-9.2%+1.7%+59.7%
Q2 2022-8.2%-27.9%-53.8%
Q1 2022+22.4%+61.8%+41.2%
Q3 2021
Q2 2021
Q1 2021
Q3 2020
Q1 2020
Q3 2019
Q1 2019
Q2 2018
Q2 2016
Q3 2014
Q1 2014
Q3 2013
Q2 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro